Monoamine Oxidase Inhibitors (Type A Or B) has 2 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Carbidopa, Carbidopa Tablets. Patients taking Monoamine Oxidase Inhibitors (Type A Or B) should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Contraindicated
- 2
Contraindicated (2)
- Monoamine Oxidase Inhibitors (Type A Or B) + Carbidopa— Contraindicated with carbidopa; see CONTRAINDICATIONS section.
- Monoamine Oxidase Inhibitors (Type A Or B) + Carbidopa Tablets— Contraindicated per label contraindications section.